Prof. Dr. Eckhart Weidmann

Prof. Dr. Eckhart Weidmann

Hematologist

38+ years of experience

Fellowship, Graduation

Nordwest Hospital, Frankfurt – Germany Nordwest Hospital, Frankfurt – Germany

ChatYou are Viewing our Top Doctor

ChatChat on WhatsApp

About Prof. Dr. Eckhart Weidmann

Prof. Dr. Eckhart Weidmann is a Senior Hematologist-Oncologist with over 38 years of experience and Head of the Hematology Section at Krankenhaus Nordwest, Frankfurt. He is internationally recognised for his expertise in lymphoma, multiple myeloma, and stem cell transplantation, making him one of the best Hematology doctors in Germany.

  • 38+ years of clinical experience in Hematology and Oncology
  • Head, Hematology Section, Department of Oncology & Hematology, Krankenhaus Nordwest (since 2011)
  • Postdoctoral Research Fellow at the Pittsburgh Cancer Institute, USA
  • DFG-funded research scholarship recipient (1990)
  • Habilitation thesis on cytostatic-induced apoptosis in B- and T-cell neoplasias
  • Editor / peer reviewer for Blood, PNAS, Cancer Research, and Annals of Hematology

Qualifications & Credentials

Medical Degrees

  • Medical Studies (MD / Graduation) — Johann Wolfgang Goethe University, Frankfurt, Germany, 1980–1986
  • Doctorate (Dr. med.) — Goethe University Frankfurt, Germany, 1988
  • Habilitation in Internal Medicine — Goethe University Frankfurt, Germany, 2002 (Thesis: Cytostatic-induced apoptosis in peripheral B- and T-cell neoplasias)

Fellowships & Special Training

  • Specialist Training in Internal Medicine — Department of Hematology (Prof. Dr. D. Hoelzer), Goethe University Frankfurt, 1987–1989
  • Postdoctoral Research Fellow — Departments of Pathology, Pediatrics & Pittsburgh Cancer Institute, University of Pittsburgh, USA, 1990 (DFG scholarship)
  • Specialist Certification in Hematology and Internal Oncology — 2003

Certifications & Accreditations

  • German Medical Council Registration (Frankfurt)
  • Member — Medical Association of Frankfurt
  • Member — German Cancer Society (DKG)
  • Member — German Society for Hematology and Medical Oncology (DGHO)
  • Member — European Society of Medical Oncology (ESMO)
  • Member — American Association for Cancer Research (AACR)
  • Member — German Society for Internal Medicine (DGIM)
  • Member — Tumour Centre Rhein-Main

Areas of Expertise

Major Conditions Treated

  • Hodgkin & Non-Hodgkin Lymphoma
  • T-Cell Lymphomas
  • Multiple Myeloma
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Myelodysplastic Syndromes (MDS)
  • Anemia and Bleeding Disorders
  • Bone Marrow Failure Syndromes
  • Rare Hematological Conditions

Sub-specialties

  • Lymphoma & T-Cell Lymphoma: Specialist in diagnosis and treatment of complex lymphoma cases — a leading Hematology specialist in Frankfurt, Germany.
  • Stem Cell Transplantation: Expertise in autologous, allogeneic, and umbilical cord blood transplantation — recognised among the best Hematology doctors in Germany.
  • Translational Hematology & Apoptosis Research: Internationally recognised for research on cytostatic-induced apoptosis and pro-apoptotic protein Par-4 in haematological malignancies.

Advanced Procedures & Treatments

  • Autologous Peripheral Blood Stem Cell Transplantation
  • Allogeneic Bone Marrow Transplantation
  • Umbilical Cord Blood Transplantation
  • High-Dose Chemotherapy
  • Radiochemotherapy
  • Antibody Therapy & Targeted Therapy
  • Immunotherapy & Cytokine Therapy
  • Personalised Therapy for Haematological Malignancies
  • Bone Marrow Biopsy & Flow Cytometry
  • Therapeutic Apheresis

Professional Experience

Current Affiliation

  • Krankenhaus Nordwest, Frankfurt am Main, Germany — Head of Hematology Section, Department of Oncology & Hematology, since 1 January 2011 (Present)

Past Affiliations

  • Krankenhaus Nordwest, Frankfurt, Germany — Senior Consultant (Leitender Oberarzt), II. Medical Clinic, Hematology/Oncology, since 15 April 2003
  • Goethe University Frankfurt, Germany — Senior Consultant of Hematological Outpatient Clinic and Day Clinic, Medical Clinic III, 2002–2003
  • Goethe University Frankfurt, Germany — Deputy Senior Physician, Medical Polyclinic, Centre for Internal Medicine
  • University of Pittsburgh / Pittsburgh Cancer Institute, USA — Postdoctoral Research Fellow (DFG scholarship), 1990
  • Goethe University Frankfurt, Germany — Resident in Internal Medicine / Hematology, 1987–1989

Academic & Research Roles

  • Manuscript reviewer — Proceedings of the National Academy of Sciences (PNAS) USA, Blood, Cancer Research, Annals of Hematology, Haematologica, International Journal of Hematology
  • Habilitation supervisor and academic mentor at Goethe University Frankfurt
  • Author of multiple peer-reviewed publications on apoptosis and lymphoma biology

Key Achievements

  • 38+ years of dedicated experience in Hematology and Oncology
  • Head of Hematology Section, Krankenhaus Nordwest — one of Frankfurt's leading oncology centres
  • DFG research scholarship (1990) for postdoctoral research at the Pittsburgh Cancer Institute
  • Habilitation in Internal Medicine (2002)
  • Pioneer in research on cytostatic-induced apoptosis and Par-4 protein

Awards & Recognitions

National & International Awards

  • DFG (German Research Foundation) Research Scholarship — 1990 (Pittsburgh Cancer Institute)
  • FOCUS Top Hospital Listing — Krankenhaus Nordwest under his leadership

Professional Memberships

  • American Association for Cancer Research (AACR)
  • German Cancer Society (DKG)
  • German Society for Hematology and Medical Oncology (DGHO)
  • European Society of Medical Oncology (ESMO)
  • German Society for Internal Medicine (DGIM)
  • Tumour Centre Rhein-Main
  • Medical Association of Frankfurt

Research & Publications

Published Papers (Selected)

  • Weidmann E, et al. Habilitation thesis: "Cytostatic-induced apoptosis in peripheral B- and T-cell neoplasias: synergistic and antagonistic mechanisms and significance of pro-apoptotic protein Par-4." Goethe University Frankfurt, 2002.
  • Weidmann E, et al. Multiple peer-reviewed publications on lymphoma, T-cell biology, and apoptosis. Full citation list available via PubMed.

Ongoing Research & Clinical Interests

  • Lymphoma — diagnosis, treatment, and clinical outcomes
  • T-cell lymphomas and apoptosis pathways
  • Multiple myeloma and stem cell transplant outcomes
  • Personalised therapy for haematologic malignancies
  • Pro-apoptotic protein research (Par-4)

Estimated Treatment Costs

Procedure / ConsultationEstimated Cost (EUR)Estimated Cost (USD)
Hematology-Oncology Consultation€250 – €500$270 – $540
Chemotherapy (per cycle)€2,000 – €8,000$2,150 – $8,650
Targeted & Antibody Therapy (per cycle)€5,000 – €15,000$5,400 – $16,200
Autologous Stem Cell Transplant€60,000 – €100,000$65,000 – $108,000
Allogeneic Stem Cell Transplant€120,000 – €200,000$130,000 – $216,000
Bone Marrow Biopsy & Flow Cytometry€800 – €2,500$865 – $2,700

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Frequently Asked Questions

1. What advanced technologies does Prof. Dr. med. Eckhart Weidmann use in Hematology treatment?

Prof. Dr. med. Eckhart Weidmann employs the latest evidence-based tools and minimally invasive techniques relevant to Hematology. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.

2. What conditions does Prof. Dr. med. Eckhart Weidmann specialize in treating?

Prof. Dr. med. Eckhart Weidmann is a specialist in Hematology, treating a broad spectrum of conditions in this field — including both common presentations and complex, rare cases. International patients seek treatment for conditions requiring expert Hematology care in Frankfurt, Germany.

3. How do I book an appointment with Prof. Dr. med. Eckhart Weidmann?

Appointments with Prof. Dr. med. Eckhart Weidmann can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Prof. Dr. med. Eckhart Weidmann?

Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. med. Eckhart Weidmann, including medical visa invitation letters, airport transfers, and local accommodation coordination.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.

6. Does Prof. Dr. med. Eckhart Weidmann offer second opinions for Hematology cases?

Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Hematology specialist in Frankfurt, Germany.

Our Impact

CancerRounds is making quality care accessible to patients around the world

Send your reports
5000+ Specialists
Send your reports
500+ Partner Hospitals
Send your reports
10000+ Patients Served
Send your reports
98% Patient Satisfaction

Why Choose CancerRounds for Your Treatment?

World-Class Care

World-Class Care Highly

Skilled oncologists provide top-tier medical services

Affordable Treatment

Affordable Treatment

Costs are significantly lower than in Western countries.

Comprehensive Packages

Comprehensive Packages

We offer all-inclusive plans covering surgery, stay, and aftercare.

Easy Accessibility

Easy Accessibility

Well-connected airports and international flight routes. Proven Success: High patient satisfaction and positive treatment outcomes

Proven Success

Proven Success

High patient satisfaction and positive treatment outcomes


    Get FREE Evaluation

    Treatment plan and quote within 2 days

    FREE, No-Obligation Expert Evaluation

    👥 Trusted by Over 10,000 Patients Worldwide

    🤝 Expert Handholding at Every Step

    Your information is safe and confidential.